米国の体外診断薬市場規模、シェア、動向分析レポート：製品別（試薬、機器、サービス）、技術別（免疫測定法、分子診断法）、用途別、最終用途別、セグメント別予測、2024年～2030年

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, And Segment Forecasts, 2024 - 2030

米国の体外診断薬市場の成長と動向 Grand View Research社の最新レポートによると、米国の体外診断薬市場規模は2030年までに375億8000万米ドルに達すると予測されている。同市場は、2024年から2030年にかけてC... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Grand View Research グランドビューリサーチ	2023年12月29日	US$3,950 シングルユーザライセンス（印刷不可）ライセンス・価格情報・注文方法はこちら	358	英語

1～３営業日

サマリー

米国の体外診断薬市場の成長と動向

Grand View Research社の最新レポートによると、米国の体外診断薬市場規模は2030年までに375億8000万米ドルに達すると予測されている。同市場は、2024年から2030年にかけてCAGR 3.70%で成長すると予測されている。血液、尿、組織などの生体流体の診断検査を行う医療機器は、体外診断薬（IVD）として知られている。体外診断用医薬品は、薬物療法の研究、感染症、自己免疫疾患、様々な疾患の特定と評価に使用される。

慢性疾患や病原性疾患の有病率の上昇、人口の高齢化、ポイント・オブ・ケア検査の普及、個別化医療は、国内における体外診断用医薬品（IVD）検査の需要を増加させると予想される。さらに、ゲノミクスとプロテオミクスの発展に伴い、分子診断学がその範囲を拡大し、新たな多様な病態特異的指標と検査を導入することで、この業界は新たな展望を見いだそうとしている。

遺伝性疾患、心血管疾患、神経疾患など、いくつかの疾患は一般的になりつつある。心血管疾患（CVD）は米国における主要な死因であり、疾病対策予防センター（CDC）によれば、毎年推定65万9000人が死亡している。このため、早期診断に対する国民の意識が高まり、定期的な診断が増加しており、この両者が市場全体の発展を支えている。

先進的な体外診断用医薬品の発売が市場の急拡大を後押ししている。さらに、市場関係者や研究機関は、国内の疾病負担全体を軽減するために、新規製品の開発に積極的に取り組んでいる。例えば、2021年5月、カリフォルニア大学は超高感度分子検査を開発した。この検査はチップ技術に基づいており、A型インフルエンザとSARS-CoV-2抗原の存在を検出できる。この検査は、Point-of-Care（PoC）検査への転換を目指し、さらなる研究が進められている。

ポイントオブケア検査施設におけるIVD検査の採用は急速に増加している。複数の企業が在宅ケア施設向け検査の立ち上げに注力していることから、業界の勢力図に変化が生じている。さらに、2021年にはFDAも在宅分子診断検査を優先した。2021年3月、BATM Advanced Communications LimitedはCOVID-19検出用の分子診断自己検査キットの発売を発表した。

この市場は、診断ラボが完全自動化ツールを採用するようになり、力を増している。手動や半自動装置とは対照的に、自動化装置は拡張性に優れ、高い性能を満たし、検査技師の作業時間を短縮し、バッチテストを排除し、医師に迅速な結果を提供する。このような利点から、市場参加者はますます自動化機器の開発に取り組んでいる。

さらに、検査室の自動化は、診断検査の効率と有効性を促進し、迅速化し、改善する。検体チューブの装填から全ての主要な検査分野の所見の提供まで、総合的な検査室自動化システムは検査プロセスの全ての部分を扱うことができる。より多くのメーカーがより幅広い自動化の選択肢を持って市場に参入するにつれ、臨床診断ビジネスにおけるラボ自動化の進化は加速し続けている。

SARS-CoV-2ウイルスの検出に利用されているため、COVID-19パンデミックは分子診断ツールへの需要を高めている。また、COVID-19に罹患した入院患者の間では、血糖値、トロポニン値、その他様々なパラメータを測定するための検査キットや消耗品の需要が急増した。その結果、パンデミックの間、体外診断用医薬品の使用量が増加し、市場の成長を促進した。

米国の体外診断薬市場レポートハイライト

- 製品別では、遺伝子検査需要の増加と先進的ながん診断検査が米国で利用可能になったことから、試薬分野が米国体外診断用医薬品市場で大きなシェアを占めている。

- 凝固部門は急成長が見込まれる。心血管疾患、血液関連疾患、自己免疫疾患の有病率の上昇が凝固検査の需要を押し上げると予想される。

- がん分野は、疾病の有病率の増加と疾病の早期診断に関する人々の意識の高まりにより、予測期間中に最も速いCAGRで成長すると予測される。

- 主な市場参入企業としては、QIAGEN、F. Hoffman-La Roche Ltd.、Thermo Fisher Scientific, Inc.、Danaher Corporation、Illuminaなどが挙げられる。

ページTOPに戻る

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 U.S. IVD Market Variables, Trends, & Scope
3.1 IVD Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Regulatory Framework
3.3 Market Driver Analysis
3.3.1 Growing Geriatric Population
3.3.2 Technological Advancements
3.3.3 Increasing Demand For Poc Facilities
3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
3.3.5 Outbreak Of Covid-19
3.4 Market Restraint Analysis
3.4.1 Higher Cost Of Devices
3.4.2 Stringent Regulatory Policies
3.5 Value Chain Analysis
3.5.1 Value Chain Analysis/Route To Market
3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.7 Porter’s Five Forces Analysis
Chapter 4 U.S. IVD Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 U.S. In Vitro Diagnostic Market: Products Movement Analysis
4.2 Instruments
4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Reagents
4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 Services
4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 U.S. IVD Market-Segment Analysis, By Technology, 2018 - 2030 (USD Million)
5.1 In Vitro Diagnostics Market: Technology Movement Analysis
5.2 Immunoassay
5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2 Instruments
5.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.3 Reagents
5.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.4 Services
5.2.4.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Hematology
5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.2 Instruments
5.3.2.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.3 Reagents
5.3.3.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
5.3.4 Services
5.3.4.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Clinical Chemistry
5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.2 Instruments
5.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.3 Reagents
5.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
5.4.4 Services
5.4.4.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Molecular Diagnostics
5.5.1 Moecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.2 Instruments
5.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.3 Reagents
5.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
5.5.4 Services
5.5.4.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Coagulation
5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.2 Instruments
5.6.2.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.3 Reagents
5.6.3.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
5.6.4 Services
5.6.4.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Microbiology
5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.2 Instruments
5.7.2.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.3 Reagents
5.7.3.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
5.7.4 Services
5.7.4.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
5.8 Others
5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8.2 Instruments
5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8.3 Reagents
5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.8.4 Services
5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 U.S. IVD Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
6.1 In Vitro Diagnostic Market: End-Use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 Hospitals Market, By Technology
6.2.2.1 Immunoassay
6.2.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.3 Hematology
6.2.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.5 Clinical Chemistry
6.2.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.7 Molecular Diagnostics
6.2.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.9 Coagulation
6.2.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.11 Microbiology
6.2.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.13 Others
6.2.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Laboratory
6.3.1 Laboratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 Laboratory Market, By Technology
6.3.2.1 Immunoassay
6.3.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.3 Hematology
6.3.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.5 Clinical Chemistry
6.3.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.7 Molecular Diagnostics
6.3.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.9 Coagulation
6.3.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.11 Microbiology
6.3.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.13 Others
6.3.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Home Care
6.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2 Home Care Market, By Technology
6.4.2.1 Immunoassay
6.4.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.3 Hematology
6.4.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.5 Clinical Chemistry
6.4.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.7 Molecular Diagnostics
6.4.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.9 Coagulation
6.4.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.11 Microbiology
6.4.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.13 Others
6.4.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2 Others Market, By Technology
6.5.2.1 Immunoassay
6.5.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.3 Hematology
6.5.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.5 Clinical Chemistry
6.5.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.7 Molecular Diagnostics
6.5.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.9 Coagulation
6.5.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.11 Microbiology
6.5.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.13 Others
6.5.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 U.S. IVD Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
7.1 U.S. In Vitro Diagnostics Market: Application Movement Analysis
7.2 Infectious Diseases
7.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.1 Upper Respiratory
7.2.1.1.1 Upper Respiratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.2 Gastrointestinal Panel Testing
7.2.1.2.1 Gastrointestinal Panel Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.3 Methicillin-Resistant Staphylococcus Aureus (MRSA)
7.2.1.3.1 MRSA Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.4 Clostridium Difficile
7.2.1.4.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.5 Vancomycin-Resistant Enterococci (VRE)
7.2.1.5.1 VRE Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.6 Carbapenem-Resistant Bacteria
7.2.1.6.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.7 Flu
7.2.1.7.1 Flu Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.8 Respiratory Syncytial Virus (RSV)
7.2.1.8.1 RSV Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.9 Candida
7.2.1.9.1 Candida Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.10 Tuberculosis (TB) And Drug-Resistant TB
7.2.1.10.1 TB And Drug-Resistant TB Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.11 Meningitis
7.2.1.11.1 Meningitis Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.12 Chlamydia
7.2.1.12.1 Chlamydia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.13 Gonorrhoea
7.2.1.13.1 Gonorrhoea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.14 HIV
7.2.1.14.1 HIV Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.15 Hepatitis C
7.2.1.15.1 Hepatitis C Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.16 Hepatitis B
7.2.1.16.1 Hepatitis B Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.1.17 Other Infectious Diseases
7.2.1.17.1 Other Infectious Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Diabetes
7.3.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Oncology
7.4.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Cardiology
7.5.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Nephrology
7.6.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Autoimmune Diseases
7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Drug Testing
7.8.1 Drug Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.9 Hematologic Diseases
7.9.1 Hematologic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.10 Others
7.10.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 U.S. IVD Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
8.1 Regional Analysis - The U.S. IVD Market
8.1.1 Trends In The U.S. IVD Market
8.1.2 Key Country Dynamics
8.1.3 Risk Factors And Major Chronic Diseases In The U.S.
8.1.4 Competitive Scenario
8.1.5 Regulatory Framework
8.1.6 Reimbursement Scenario
8.1.7 U.S. IVD Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Competitive Analysis
9.1. Participant Categorization
9.1.1. BD
9.1.1.1. Overview
9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. Bio-Rad Laboratories, Inc.
9.1.2.1. Overview
9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Abbott
9.1.3.1. Overview
9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Agilent Technologies, Inc.
9.1.4.1. Overview
9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Siemens Healthcare GmbH
9.1.5.1. Overview
9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Qiagen
9.1.6.1. Overview
9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. bioMerieux
9.1.7.1. Overview
9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Quidel Corporation
9.1.8.1. Overview
9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. F. Hoffmann-La Roche, Ltd.
9.1.9.1. Overview
9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.2. Participant’s Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Company Market Share Analysis, 2023
9.6. Strategy Mapping
9.6.1. Expansion
9.6.2. Acquisition
9.6.3. Product/Service Launch
9.6.4. Others
Chapter 10. Analyst View

ページTOPに戻る

Table of Contents

Summary

U.S. In Vitro Diagnostics Market Growth & Trends

The U.S. in vitro diagnostics market size is expected to reach USD 37.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 3.70% from 2024 to 2030. Medical instruments that perform diagnostic tests on bio-fluids including blood, urine, and tissues are known as in vitro diagnostics (IVD). The IVD tests are used to study pharmacological therapy and to identify and evaluate infectious diseases, autoimmune disorders, and a variety of medical ailments.

The rising prevalence of chronic and pathogenic diseases, the aging population, the increasing popularity of point-of-care testing, and personalized medicine are anticipated to increase the demand for IVD testing in the country. Moreover, with developments in genomics & proteomics, this industry is seeing new prospects as molecular diagnostics expands its reach and introduces a new variety of condition-specific indicators and tests.

Several ailments, such as genetic, cardiovascular, and neurological disorders, are becoming more common. Cardiovascular diseases (CVDs) are the major cause of death in the U.S., killing an estimated 659,000 people each year, as per the Centers for Disease Control and Prevention (CDC). This has resulted in a significant public awareness about early diagnosis and a rise in routine diagnosis, both of which support the market's overall development.

The launch of new advanced IVD products is assisting the market's rapid expansion. Moreover, market players and research institutes are actively involved in the development of novel products to reduce the overall disease burden in the country. For instance, in May 2021, the University of California developed an ultrasensitive molecular test. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is under further study for conversion into a Point-of-Care (PoC) test.

The adoption of IVD testing at the point-of-care testing facilities is increasing rapidly. As several players are focusing on launching tests for home care facilities, there has been a shift in the industry dynamics. Moreover, in 2021, FDA also prioritized home-based molecular diagnostics tests. In March 2021, BATM Advanced Communications Limited announced the launch of its molecular diagnostics self-test kit for the detection of COVID-19.

The market is gaining strength as diagnostic laboratories increasingly employ fully automated tools. Automated instruments, as opposed to manual and semi-automated equipment, are more expandable, meet high level of performance, reduce technologists' hands-on time, eliminate batch testing, and provide faster results to physicians. Market participants are increasingly working on building automated instruments as a result of these benefits.

Furthermore, laboratory automation facilitates, expedites, and improves the efficiency and efficacy of diagnostic tests. From loading specimen tubes to providing findings for all major laboratory disciplines, a total lab automated system can handle all parts of the testing process. As more manufacturers enter the market with broader automation choices, the evolution of lab automation in the clinical diagnostics business is continuing to accelerate.

Since it is utilized to detect the SARS-CoV-2 virus, the COVID-19 pandemic has increased the demand for molecular diagnostics tools. Additionally, among hospitalized patients suffering from COVID-19, there was a surge in demand for test kits and consumables for measuring blood glucose levels, troponin levels, and a variety of other parameters. As a result, the usage of IVD devices increased during the pandemic and propelled the market growth.

U.S. In Vitro Diagnostics Market Report Highlights

• By product, the reagent segment held a larger share of the U.S. IVD market owing to the increasing demand for genetic testing and the availability of advanced cancer diagnostic tests in the country

• The coagulation segment is expected to be the fastest-growing segment. The rising prevalence of cardiovascular diseases, blood-related disorders, and autoimmune diseases is expected to boost the demand for coagulation testing

• The oncology segment is anticipated to grow at the fastest CAGR over the forecast period owing to the increasing prevalence of disease and increasing awareness among people about early diagnosis of diseases

• A few of the key market players include QIAGEN; F. Hoffman-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Danaher Corporation; Illumina

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（診断薬）の最新刊レポート

Grand View Research 社の最新刊レポート

本レポートと同じKEY WORD（immunoassay）の最新刊レポート

よくあるご質問

Grand View Research社はどのような調査会社ですか?

グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

米国の体外診断薬市場規模、シェア、動向分析レポート：製品別（試薬、機器、サービス）、技術別（免疫測定法、分子診断法）、用途別、最終用途別、セグメント別予測、2024年～2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（診断薬）の最新刊レポート

Grand View Research 社の最新刊レポート

本レポートと同じKEY WORD（immunoassay）の最新刊レポート

よくあるご質問

Grand View Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?